Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate

NCT02578602 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02578602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02578602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR Techniques in the Evaluation of Hepatocellular Carcinoma: Gadoxetate
Lead sponsor
University of Southern California
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2010
Completion date
June 30, 2015
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult hepatocellular carcinoma, advanced adult hepatocellular carcinoma, bclc stage 0 adult hepatocellular carcinoma, bclc stage a adult hepatocellular carcinoma, bclc stage b adult hepatocellular carcinoma, bclc stage c adult hepatocellular carcinoma, bclc stage d adult hepatocellular carcinoma, localized non-resectable adult liver carcinoma, localized resectable adult liver carcinoma